Taysha Gene Therapies, Inc.·4

Mar 13, 4:15 PM ET

Alam Kamran 4

4 · Taysha Gene Therapies, Inc. · Filed Mar 13, 2025

Insider Transaction Report

Form 4
Period: 2025-03-11
Alam Kamran
CHIEF FINANCIAL OFFICER
Transactions
  • Tax Payment

    Common Stock

    2025-03-11$1.69/sh29,843$50,4351,242,094 total
Footnotes (1)
  • [F1]Represents shares withheld by the Issuer to satisfy the tax withholding obligations triggered by the vesting and settlement of restricted stock units and does not represent a discretionary transaction by the Reporting Person.

Documents

1 file
  • 4
    form4-03132025_040301.xmlPrimary